B Acute Lymphoblastic Leukemia, BCR-ABL1-Like (DBCOND0158586)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Asparaginase Escherichia coli
- Beta-D-Glucose
- Calcium
- Clofarabine
- Cortisone
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin
- Dexamethasone
- Doxorubicin
- Ethanol
- Etoposide
- Hydrocortisone
- Hydrocortisone succinate
- Leucovorin
- Levoleucovorin
- Mercaptopurine
- Methopterin
- Methotrexate
- Pegaspargase
- Prednisone
- Sodium succinate
- Sulfate ion
- Tioguanine
- Vincristine
treatment 3 active_not_recruiting NCT05602194 Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma supportive_care 3 recruiting